Indian company pledges to sell injectable lenacapavir in low- and middle-income countries for only $40 a year
Methodically tracking the collapse. Climate data. Extreme weather. The long emergency.
Indian company pledges to sell injectable lenacapavir in low- and middle-income countries for only $40 a year